EXOSOMM is the first and only company in the world to produce *active milk exosomes* at *industrial scale*, with a shelf life exceeding one year. Our proprietary, patent-protected process sustainably isolates exosomes from cow milk whey—a dairy side-stream—without the use of chemicals, transforming waste into high-value therapeutic solutions for inflammatory diseases.

What Are Milk Exosomes?
Exosomes are nano-sized vesicles that carry microRNAs, proteins, and lipids, acting as messengers for cellular communication. In milk, these exosomes are naturally bioavailable, surviving digestion and delivering bioactive signals that support immune regulation, gut health, and systemic anti-inflammatory responses.

​

​Why Aren’t Milk Exosomes Commercially Available?
Despite their immense therapeutic potential, milk exosomes have remained inaccessible at scale due to the complexity of isolating them without damaging their structure or function. Until now, no company has succeeded in developing a scalable, shelf-stable, and biologically active milk exosome product—making EXOSOMM a global first.